Rapamycin

Rapamycin: The Promise and Perils of an Anti-Aging Drug

Rapamycin is one of the most intriguing-and controversial-compounds in modern longevity science. Originally developed as an immunosuppressant, it has drawn growing interest from researchers and aging scientists for its potential role in lifespan extension and its influence on the biology of aging.

In Rapamycin: The Promise and Perils of an Anti-Aging Drug, author Alex Apple continues the Promise and Perils series-an evidence-based exploration of emerging compounds and ideas in longevity science. Each book in the series is written to stand on its own, offering context, history, and critical analysis without hype or prescription.

Rather than fear-mongering or promotion, this volume examines what rapamycin is, how it works in the body, and why it has become a focal point in aging research-along with the legitimate risks, uncertainties, and ethical questions that surround its discussion.

Inside, readers will explore:

• The origins of rapamycin and how it was discovered

• How the mTOR pathway relates to aging, metabolism, and cellular growth

• What animal and early human research suggests-and what it does not

• Potential risks, trade-offs, and unanswered questions

• Ethical, medical, and personal considerations surrounding longevity drugs

This book does not promote rapamycin as a cure, treatment, or solution. Instead, it provides balanced analysis and scientific context-empowering readers to better understand the broader conversation unfolding at the intersection of medicine, aging, and emerging science.

Written for curious readers, health-conscious individuals, and those interested in longevity research, Rapamycin offers a thoughtful, standalone examination within the Promise and Perils series.